Document Detail


Developing a synagis clinic for respiratory syncytial virus prophylaxis.
MedLine Citation:
PMID:  11552574     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Respiratory Syncytial Virus (RSV) can be devastating to premature infants and children with chronic lung disease. Palivizumab (Synagis) is a monoclonal antibody that is administered monthly by injection to prevent RSV infection in infants at high risk. This article describes a nurse-run ambulatory clinic to provide RSV prophylaxis. Coordination with other agencies, including community neonatal intensive care units, was essential to the clinic's success. For each of its first 2 years of operation, 24 infants and their families attended the clinic once each month for 5 months throughout the RSV season. Outcomes for this patient population were compared to outcomes reported in the literature, and include reduced RSV-related hospitalizations and reduced days of hospitalization.
Authors:
S Coffman; J Peck; C S Rasmussen
Related Documents :
12904604 - Pulmonary surfactant disaturated-phosphatidylcholine (dspc) turnover and pool size in n...
1484754 - Delayed compliance increase in infants with respiratory distress syndrome following syn...
15765744 - Relationship between atopic status and nasal interleukin 10 and 11 levels in infants wi...
20337964 - Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronch...
24729634 - Hearing versus listening: attention to speech and its role in language acquisition in d...
920164 - Influence of oral lysozyme administration on serum immunoglobulin and intestinal secret...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  MCN. The American journal of maternal child nursing     Volume:  26     ISSN:  0361-929X     ISO Abbreviation:  MCN Am J Matern Child Nurs     Publication Date:    2001 Sep-Oct
Date Detail:
Created Date:  2001-09-12     Completed Date:  2001-10-04     Revised Date:  2007-10-29    
Medline Journal Info:
Nlm Unique ID:  7605941     Medline TA:  MCN Am J Matern Child Nurs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  246-51; quiz 252     Citation Subset:  IM; N    
Affiliation:
Sierra Health Services, Las Vegas, N.V. USA. scoffman@sierrahealth.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ambulatory Care Facilities / organization & administration*
Antibodies, Monoclonal / therapeutic use*
Antiviral Agents / therapeutic use*
Case Management / organization & administration
Child Health Services / organization & administration*
Humans
Infant
Infant, Newborn
Infant, Premature
Nevada
Outcome Assessment (Health Care)
Respiratory Syncytial Virus Infections / prevention & control*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antiviral Agents; 0/palivizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Making evidence-based practice a reality in your institution.
Next Document:  Teaching mothers about childhood immunizations.